Examples include semaglutide (brand names Ozempic and Wegovy), tirzepatide (brand name Mounjaro), and liraglutide (brand names Victoza and Saxenda)
The D2/D3 agonist PD128907 (R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol) inhibits stimulated pyloric relaxation and spontaneous gastric emptying
TRIUMPH-4: Osteoarthritis pain signal Because TRIUMPH-4 specifically enrolled participants with symptomatic knee osteoarthritis, it also collected WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) pain data
there was no significant difference in the response to treatment between the groups
Temporarily putting aside the desire for head-to-head RCTs, systematic reviews of clinical trial data (both Phase 3 registration trials and smaller studies), describe FFM loss relative to total weight loss
Affectionately called 'Lizzie, or Gilly' by diabetic patients and marketed as 'Byetta', exenatide was the first slow-release GLP-1 mimic to reach the market (Schuler, Shearin)